Rubenstein Law’s Miriam Fresco Agrait Takes on Key Role in Prominent Depo-Provera Case

Miami, FL — In a significant development in the legal circles, Miriam Fresco Agrait, a partner at Rubenstein Law, has been appointed to a key leadership role in the ongoing multidistrict litigation concerning the contraceptive Depo-Provera. Her new position as a member of the plaintiffs’ leadership team marks a critical step in the complex lawsuit involving claims of undisclosed severe side effects from the use of the drug. Depo-Provera, a widely-used injectable contraceptive, has come under scrutiny after numerous plaintiffs alleged serious health consequences directly linked to the medication, which they claim were not adequately … Read more

Federal Court Mobilizes Top Legal Team to Tackle Depo-Provera Brain Tumor Claims Against Pfizer

PENSACOLA, Fla. — A significant legal development emerged this month as a federal judge appointed 56 attorneys to spearhead a large-scale legal battle involving the contraceptive injection Depo-Provera. This injection, developed by pharmaceutical giant Pfizer Inc., has become the center of controversy following over 70 lawsuits that allege a link between its use and the development of brain tumors in patients. U.S. District Judge M. Casey Rodgers, operating within the Northern District of Florida, issued the order on March 16. Among the appointed, Chris Seeger has been named lead counsel with Ellen Relkin and Bryan … Read more

Depo-Provera Users File Lawsuits Claiming Birth Control Shot Linked to Brain Tumors, Seek Justice Against Pharmaceutical Giants

LOS ANGELES — A series of U.S. lawsuits claim that Depo-Provera, a birth control injection, is linked to the development of meningioma brain tumors, with litigations pointing fingers at pharmaceutical giants for not adequately warning users of the possible risks. The first such lawsuit was launched in October 2024 by a California woman who had used the contraceptive from 2005 to 2021 and then required surgery to remove a brain tumor. As litigation intensifies, approximately 70 related claims were filed as of February 2025. These cases are likely to burgeon with many consolidated into a … Read more

New Guide Unveils Critical Health Risks and Legal Challenges Linked to Depo-Provera Use

DALLAS — On Point Legal Leads, a provider renowned for its mass tort leads and legal consultation services, unveiled a detailed guide focusing on the litigation and safety controversies surrounding Depo-Provera. The guide, titled “Depo-Provera: Litigation Controversial Safety Warnings,” dives into numerous health and legal challenges posed by the contraceptive, aimed at equipping lawyers, patients, and the healthcare industry with vital knowledge and resources. Released on Nov. 20, 2024, the analysis involves comprehensive insights into the significant health risks linked to Depo-Provera, including an increased risk of developing meningioma. Following a 2024 study published by … Read more